Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 10/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8562533 | 0.87 | OPRK1 (0.54) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 | |
| SCHEMBL8564709 | 0.86 | OPRK1 (0.59) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 | |
| SCHEMBL8557841 | 0.84 | OPRK1 (0.59) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 | |
| SCHEMBL8557875 | 0.82 | OPRK1 (0.61) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 | |
| SCHEMBL8561676 | 0.81 | OPRK1 (0.51) | OPRK1OPRD1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8560834 | 0.81 | OPRK1 (0.77) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 | |
| SCHEMBL8565643 | 0.81 | OPRK1 (0.51) | OPRK1OPRD1CYP3A4CYP2D6CYP2C9 | |
| Hydrochloric Acid SCHEMBL8561341 | 0.80 | OPRK1 (0.50) | OPRK1OPRD1CYP3A4CYP2D6CYP2C9 | |
| Hydrochloric Acid SCHEMBL8556861 | 0.80 | OPRK1 (0.76) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 | |
| SCHEMBL8562036 | 0.79 | OPRK1 (0.48) | OPRK1OPRM1OPRD1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5756730-A | Process for preparing analgesic compounds | SANKYO COMPANY, LIMITED (JP) | 1998-05-26 | — | — | US | disclosed |
| US-5656758-A | AMIDATION OF AN AMINE-CONTAINING THIOMORPHOLINE OR PIPERAZINE COMPOUND | SANKYO COMPANY, LIMITED (JP) | 1997-08-12 | — | — | US | disclosed |
| US-5512567-A | KAPPA-RECEPTOR AGONISTS | SANKYO COMPANY, LIMITED (JP) | 1996-04-30 | — | — | US | disclosed |
| US-5270327-A | Piperidine derivatives | SANKYO COMPANY, LIMITED (JP) | 1993-12-14 | — | — | US | disclosed |
| EP-0356247-B1 | ANALGESIC CARBOXYLIC ACID AMIDE DERIVATIVES | Sankyo Company Limited (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-5021413-A | Analgesic thiomorpholins their preparation, and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1991-06-04 | — | — | US | disclosed |
| EP-0356247-A1 | Analgesic carboxylic acid amide derivatives | Sankyo Company Limited (JP) | 1990-02-28 | — | — | EP | disclosed |